Free Trial

Harmony Biosciences (HRMY) News Today

Harmony Biosciences logo
$33.79 -0.38 (-1.11%)
Closing price 04:00 PM Eastern
Extended Trading
$33.74 -0.05 (-0.13%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HRMY Latest News

Harmony Biosciences Holdings, Inc. stock logo
Two Sigma Investments LP Buys 132,595 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Two Sigma Investments LP increased its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 92.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 275,594 shares of the company's stock after buying an
Harmony Biosciences Holdings, Inc. stock logo
Voloridge Investment Management LLC Grows Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Voloridge Investment Management LLC boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 24.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 356,072 shares of t
Harmony Biosciences Holdings, Inc. stock logo
Rafferty Asset Management LLC Takes Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Rafferty Asset Management LLC purchased a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,105 share
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Deutsche Bank AG
Deutsche Bank AG grew its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 28.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 85,949 shares of the company's stock after purchasing an additional 18,939
Harmony Biosciences Holdings, Inc. stock logo
venBio Partners LLC Trims Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
venBio Partners LLC reduced its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 12.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 539,194 shares of the company's stock after selling 75,400 shares during the
Harmony Biosciences Holdings, Inc. stock logo
Valor Management LLC Sells 4,600,000 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Valor Management LLC cut its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 41.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 6,618,033 shares of the company's stock after selling 4,600,000 shares d
Harmony Biosciences Holdings, Inc. stock logo
Man Group plc Acquires 58,642 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Man Group plc boosted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 37.7% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 214,113 shares of the company's stock after buying an additional 58,642 shares
Harmony Biosciences Holdings, Inc. stock logo
Nomura Holdings Inc. Has $1.81 Million Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Nomura Holdings Inc. raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 187.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,607 shares of the company's stock after acq
Harmony Biosciences Holdings, Inc. stock logo
Janus Henderson Group PLC Increases Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Janus Henderson Group PLC increased its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 31.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 221,063 shares of
Harmony Biosciences Holdings, Inc. stock logo
BNP Paribas Financial Markets Invests $2.03 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
BNP Paribas Financial Markets purchased a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 58,857 shares of the company's stock, valued at approximately $2,025,000
Harmony Biosciences Holdings, Inc. stock logo
Gotham Asset Management LLC Sells 16,220 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Gotham Asset Management LLC reduced its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 24.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 50,502 shares of the company's stock after selling 16,220 shares
Harmony Biosciences Holdings, Inc. stock logo
Graham Capital Management L.P. Acquires Shares of 14,690 Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Graham Capital Management L.P. bought a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 14,690 shares of the company's stock, valued at appr
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Position Increased by Northern Trust Corp
Northern Trust Corp boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 37.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 404,462 shares of the company's stock after pu
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences (NASDAQ:HRMY) Upgraded at Cantor Fitzgerald
Cantor Fitzgerald raised Harmony Biosciences to a "strong-buy" rating in a research report on Tuesday.
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by Jacobs Levy Equity Management Inc.
Jacobs Levy Equity Management Inc. raised its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 39.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 313,013 sh
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Holdings Boosted by D. E. Shaw & Co. Inc.
D. E. Shaw & Co. Inc. boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 35.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 480,605 shares of the company's stock after
Harmony Biosciences Holdings, Inc. stock logo
Jefferies Financial Group Inc. Has $10.52 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Jefferies Financial Group Inc. raised its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 41.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 305,600 shares of the company's stock after acquiring an additional 89,00
Harmony Biosciences Holdings, Inc. stock logo
Q2 EPS Forecast for Harmony Biosciences Lowered by Analyst
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - Analysts at HC Wainwright reduced their Q2 2025 earnings estimates for shares of Harmony Biosciences in a research report issued to clients and investors on Wednesday, May 7th. HC Wainwright analyst P. Trucchio now forecasts that th
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stake Lifted by Cresset Asset Management LLC
Cresset Asset Management LLC raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 11.8% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 71,765 shares of the company's stock after buying an additional 7,557 shares durin
Harmony Biosciences Holdings, Inc. stock logo
AQR Capital Management LLC Has $5.47 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
AQR Capital Management LLC raised its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 11.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 158,856 shares of the company'
Harmony Biosciences Holdings, Inc. stock logo
Deep Track Capital LP Makes New Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Deep Track Capital LP purchased a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 1,450,000 shares of the company's stock, valued at a
Harmony Biosciences Holdings, Inc. stock logo
43,329 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Purchased by Brevan Howard Capital Management LP
Brevan Howard Capital Management LP bought a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 43,329 shares of the company's stock, valued at approxima
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences (NASDAQ:HRMY) Announces Quarterly Earnings Results
Harmony Biosciences (NASDAQ:HRMY - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported $0.78 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.19. Harmony Biosciences had a net margin of 17.98% and a return on equity of 23.16%. The business's quarterly revenue was up 19.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.67 earnings per share.
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences (NASDAQ:HRMY) Shares Gap Up Following Strong Earnings
Harmony Biosciences (NASDAQ:HRMY) Shares Gap Up After Strong Earnings
Harmony Biosciences Holdings, Inc. stock logo
Needham & Company LLC Reaffirms "Buy" Rating for Harmony Biosciences (NASDAQ:HRMY)
Needham & Company LLC reissued a "buy" rating and set a $49.00 target price on shares of Harmony Biosciences in a report on Tuesday.
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Purchased by Algert Global LLC
Algert Global LLC lifted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 153.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 230,908 shares of the
Harmony Biosciences Holdings, Inc. stock logo
11,497 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Acquired by Susquehanna Fundamental Investments LLC
Susquehanna Fundamental Investments LLC acquired a new stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 11,497 shares of the company's st
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Holdings Raised by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP boosted its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 15.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,213,029 shares of the c
Harmony Biosciences Holdings, Inc. stock logo
Raymond James Financial Inc. Makes New $1.30 Million Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Raymond James Financial Inc. acquired a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 37,907 shares of the company's stock, valued at appro
Harmony Biosciences's Earnings: A Preview
Harmony Biosciences Holdings, Inc. stock logo
Aquatic Capital Management LLC Buys Shares of 11,127 Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Aquatic Capital Management LLC bought a new position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,127 shares of the company's stock, valued at approx
Harmony Biosciences Holdings, Inc. stock logo
Wells Fargo & Company MN Reduces Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Wells Fargo & Company MN trimmed its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 84.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,005 shares of the compa
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Rating of "Buy" from Analysts
Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) have been given an average rating of "Buy" by the nine research firms that are presently covering the company, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average tw
Harmony Biosciences Holdings, Inc. stock logo
Q1 EPS Estimate for Harmony Biosciences Reduced by Analyst
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - HC Wainwright cut their Q1 2025 EPS estimates for shares of Harmony Biosciences in a report released on Monday, April 28th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share of $0.78 for
Harmony Biosciences Holdings, Inc. stock logo
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Position Reduced by PDT Partners LLC
PDT Partners LLC decreased its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 50.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,712 shares of the company's sto
Harmony Biosciences Holdings, Inc. stock logo
First Trust Advisors LP Boosts Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
First Trust Advisors LP increased its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 255.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 169,409 shares of the com
Harmony Biosciences Holdings, Inc. stock logo
Connors Investor Services Inc. Makes New $2.50 Million Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Connors Investor Services Inc. bought a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 72,692 shares of the company's stock,
Harmony Biosciences Holdings, Inc. stock logo
18,560 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Bought by Nebula Research & Development LLC
Nebula Research & Development LLC acquired a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 18,560 shares of the
Harmony Biosciences Holdings, Inc. stock logo
UBS Group Lowers Harmony Biosciences (NASDAQ:HRMY) Price Target to $48.00
UBS Group decreased their price target on shares of Harmony Biosciences from $55.00 to $48.00 and set a "buy" rating on the stock in a research note on Monday.
Harmony Biosciences Holdings, Inc. stock logo
Barclays PLC Has $3.47 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
Barclays PLC grew its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 31.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 100,872 shares of the company's stock after purchasing an additional 24,010 shares
Get Harmony Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter.

HRMY Media Mentions By Week

HRMY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HRMY
News Sentiment

1.81

1.02

Average
Medical
News Sentiment

HRMY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HRMY Articles
This Week

7

6

HRMY Articles
Average Week

Get Harmony Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:HRMY) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners